Gershon AS - Search Results

1

Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.

Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS. Stephenson A, et al. Among authors: gershon as. Arch Intern Med. 2011 May 23;171(10):914-20. doi: 10.1001/archinternmed.2011.170. Arch Intern Med. 2011. PMID: 21606096

2

Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.

Gershon AS, Wang L, To T, Luo J, Upshur RE. Gershon AS, et al. COPD. 2008 Aug;5(4):229-34. doi: 10.1080/15412550802237507. COPD. 2008. PMID: 18671148 Free article.

3

Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.

Gershon AS, Wang C, Wilton AS, Raut R, To T. Gershon AS, et al. Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17. Arch Intern Med. 2010. PMID: 20308643

4

Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.

Gershon A, Croxford R, To T, Stanbrook MB, Upshur R, Sanchez-Romeu P, Stukel T. Gershon A, et al. Ann Intern Med. 2011 May 3;154(9):583-92. doi: 10.7326/0003-4819-154-9-201105030-00003. Ann Intern Med. 2011. PMID: 21536937 Free article.

5

Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study.

Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Gershon AS, et al. Lancet. 2011 Sep 10;378(9795):991-6. doi: 10.1016/S0140-6736(11)60990-2. Lancet. 2011. PMID: 21907862

6

The course of asthma activity: a population study.

Gershon A, Guan J, Victor JC, Wang C, To T. Gershon A, et al. J Allergy Clin Immunol. 2012 Mar;129(3):679-86. doi: 10.1016/j.jaci.2011.11.014. Epub 2011 Dec 17. J Allergy Clin Immunol. 2012. PMID: 22178637

7

Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.

Stephenson A, Seitz DP, Fischer HD, Gruneir A, Bell CM, Gershon AS, Fu L, Anderson GM, Austin PC, Rochon PA, Gill SS. Stephenson A, et al. Among authors: gershon as. Drugs Aging. 2012 Mar 1;29(3):213-223. doi: 10.2165/11599480-000000000-00000. Drugs Aging. 2012. PMID: 22332932

8

Chronic obstructive pulmonary disease and socioeconomic status: a systematic review.

Gershon AS, Dolmage TE, Stephenson A, Jackson B. Gershon AS, et al. COPD. 2012 Jun;9(3):216-26. doi: 10.3109/15412555.2011.648030. Epub 2012 Apr 12. COPD. 2012. PMID: 22497534 Free article. Review.

9

Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease.

Austin PC, Stanbrook MB, Anderson GM, Newman A, Gershon AS. Austin PC, et al. Among authors: gershon as. Ann Epidemiol. 2012 Dec;22(12):881-7. doi: 10.1016/j.annepidem.2012.09.011. Epub 2012 Oct 31. Ann Epidemiol. 2012. PMID: 23121992 Free PMC article.

10

Quantifying health services use for chronic obstructive pulmonary disease.

Gershon AS, Guan J, Victor JC, Goldstein R, To T. Gershon AS, et al. Am J Respir Crit Care Med. 2013 Mar 15;187(6):596-601. doi: 10.1164/rccm.201211-2044OC. Epub 2013 Jan 17. Am J Respir Crit Care Med. 2013. PMID: 23328526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters